Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis

Clinical Biochemistry

Volumn 47, Issue 1-2, 2014, Pages 104-110

  Eissa, Sanaa ^a   Shawky, Sherif M ^b   Matboli, Marwa ^a   Mohamed, Shaymaa ^a   Azzazy, Hassan M E ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b The American University in Cairo   (Egypt)

Author keywords

Bladder carcinoma; Gold nanoparticles; Hepatoma upregulated protein; Magnetic nanoparticles; Squamous cell carcinoma; Transitional cell carcinoma; Urinary biomarkers

Indexed keywords

GOLD NANOPARTICLE; HEPATOMA UPREGULATED PROTEIN RNA; MAGNETIC NANOPARTICLE; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER INJURY; CANCER DIAGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; INFRARED SPECTROSCOPY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PURIFICATION; SCANNING ELECTRON MICROSCOPE; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE CYTOLOGY; URINE LEVEL;

BLADDER CARCINOMA; GOLD NANOPARTICLES; HEPATOMA UPREGULATED PROTEIN; MAGNETIC NANOPARTICLES; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; URINARY BIOMARKERS;

ADULT; AGED; FEMALE; GOLD; HUMANS; LIMIT OF DETECTION; MALE; METAL NANOPARTICLES; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA; URINARY BLADDER NEOPLASMS;

EID: 84890556442     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.10.022     Document Type: Article

References (31)

1. Eissa S., Shabayek M.I., Ismail M.F., El-Allawy R.M., Hamdy M.A. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer. IUBMB Life 2010, 62:394-399.
2. Eissa S., Swellam M., Ali-Labib R., Mansour A., El-Malt O., Tash F.M. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. J Urol 2007, 178:1068-1072.
3. Chiu A.W., Huang Y.L., Huan S.K., Wang Y.C., Ju J.P., Chen M.F., et al. Potential molecular marker for detecting transitional cell carcinoma. J Urol 2002, 60:181-185.
4. Huang Y.L., Chiu A.W., Huan S.K., Wang Y.C., Ju J.P., Lu C.L. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma. Anticancer Res 2003, 23:2729-2733.
5. Eissa S., Swellam M., Amin A., Balbaa M.E., Yacout G.A. The clinical relevance of urine-based markers for diagnosis of bladder cancer. Med Oncol 2011, 28:513-518.
6. Eissa S., Swellam M., El-Khouly I.M., Kassim S.K., Shehata H., Mansour A., et al. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer, Cancer Epidemiol. Biomarkers Prev 2011, 20:1657-1664.
7. Eissa S., Swellam M., Shehata H., El-Khouly I.M., El-Zayat T., El-Ahmady O. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. J Urol 2010, 183:493-498.
8. Eissa S., Zohny S.F., Swellam M., Mahmoud M.H., El-Zayat T.M., Salem A.M. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. Clin Biochem 2008, 41:1335-1341.
9. Hutterer G.C., Karakiewicz P.I., Zippe C., Lüdecke G., Boman H., Sanchez-Carbayo M., et al. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma. BJU Int 2008, 101:561-565.
10. Kaufman D.S., Shipley W.U., Feldman A.S. Bladder cancer. Lancet 2009, 374:239-249.
11. Tsou A.P., Yang C.W., Huang C.Y., Yu R.C., Lee Y.C., Chang C.W., et al. Identification of a novel cell cycle regulated gene, HURP, over expressed in human hepatocellular carcinoma. Oncogene 2003, 22:298-307.
12. Tsou A.P., Chau G.Y., Chau Y.P., Ke Y.R., Kao H.L., Wong F.H., et al. Expression of hepatoma-up-regulated protein (HURP) in resectable hepatocellular carcinoma: dual function and clinical significance. American Association for Cancer Research Meeting 2005, 1:1281-a.
13. Azzazy H.M., Mansour M.M., Kazmierczak S.C. Nanodiagnostics: a new frontier for clinical laboratory medicine. Clin Chem 2006, 52:1238-1246.
14. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2007, 2:681-693.
15. Radwan S.H., Azzazy H.M. Gold nanoparticles for molecular diagnostics. Expert Rev Mol Diagn 2009, 9:511-524.
16. Joshi V.G. Rapid label free visual assay for the detection and quantification of viral RNA using peptide nucleic acid (PNA) and gold nanoparticles (AuNPs). Anal Chim Acta 2013, 795:1-7.
17. Fu Z., Zhou X., Xing D. Sensitive colorimetric detection of Listeria monocytogenes based on isothermal gene amplification and unmodified gold nanoparticles. Methods 2013 Aug 12, pii: S1046-2023(13)00301-0. http://dx.doi.org/ 10.1016/j.ymeth.2013.08.003.
18. Eissa S., Swellam M., El-Mosallamy H., Mourad M.S., Hamdy N., Kamel K., et al. Diagnostic value of urinary molecular 423 markers in bladder cancer. Anticancer Res 2003, 23:4347-4355.
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, 42-59. Cold Spring Harbor Laboratory Press, New York. 2nd ed.
20. Kouassi G.K., Irudayaraj J., McCarty G. Activity of glucose oxidase functionalized onto magnetic nanoparticles. Biomagn Res Technol 2005, 3:1.
21. Kouassi G.K., Irudayaraj J. Magnetic and gold-coated magnetic nanoparticles as a DNA sensor. Anal Chem 2006, 78:3232-3241.
22. Hill H.D., Mirkin C.A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat Protoc 2006, 1:324-336.
23. Smith S.D., Wheeler M.A., Plescia J., Colberg J.W., Weiss R.M., Altieri D.C. Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001, 285:324-328.
24. Storhoff J.J., Elghanian R., Mucic R.C., Mirkin C.A., Letsinger R.L. One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes. J Am Chem Soc 1998, 120:1959-1964.
25. Liu X., Atwater M., Wang J., Huo Q. Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B Biointerfaces 2007, 58:3-7.
26. Smith Z.L., Guzzo T.J. Urinary markers for bladder cancer. F1000Prime Rep 2013, [http://dx.doi.org/440 10.12703/P5-21]. [in press].
27. Xylinas E., Kluth L.A., Rieken M., Karakiewicz P.I., Lotan Y., Shariat S.F. Urine markers for detection and surveillance of bladder cancer. Urol Oncol. 2013, doi:pii: S1078-1439(13)00250-0. 10.1016/j.urolonc.2013.06.001. [in press].
28. Kamat A.M., Hegarty P.K., Gee J.R., Clark P.E., Svatek R.S., Hegarty N., et al. ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers. Eur Urol 2013, 63:4-15.
29. Shawky S.M., Bald D., Azzazy H.M. Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles. Clin Biochem 2010, 43:1163-1168.
30. Li H., Rothberg L. Label-free colorimetric detection of specific sequences in genomic DNA amplified by the polymerase chain reaction. J Am Chem Soc 2004, 126:10958-10961.
31. Li H., Rothberg L. Detection of specific sequences in RNA using differential adsorption of single-stranded oligonucleotides on gold nanoparticles. Anal Chem 2005, 77:6229-6233.